Australia markets closed

GT Biopharma, Inc. (GTBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.8300+0.0100 (+0.35%)
At close: 04:00PM EDT
2.7700 -0.06 (-2.12%)
After hours: 07:50PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
12,273
6,466
8,811
9,591
485
-
Selling general and administrative
21,384
7,110
12,446
47,924
6,279
-
Total operating expenses
33,657
13,576
21,257
57,515
6,764
-
Operating income or loss
-33,657
-13,576
-21,257
-57,515
-6,764
-
Interest expense
22
213
8
718
3,320
-
Total other income/expenses net
200
5,412
89
182
-18,212
-
Income before tax
-33,322
-7,597
-20,884
-58,013
-28,296
-
Income tax expense
0
-
-
-
-
0
Income from continuing operations
-33,322
-7,597
-20,884
-58,013
-28,296
-
Net income
-33,322
-7,597
-20,884
-58,013
-28,296
-
Net income available to common shareholders
-33,322
-7,597
-20,884
-58,013
-28,296
-
Basic EPS
-9.00
-5.58
-19.46
-61.80
-193.50
-
Diluted EPS
-9.00
-5.58
-19.46
-61.80
-193.50
-
Basic average shares
1,272
1,361
1,073
938.52
146.174
-
Diluted average shares
1,272
1,361
1,073
938.52
146.174
-